The 19th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) was held from 9/21-9/25 in Xiamen International Conference and Exhibition Center. ACT Genomics CSO, Dr. Shu-Jen Chen delivered a talk named “Prediction of Neoantigens for Tailored Immunotherapy in Asian Population" in USCACA Session: New Cancer Drugs on the Horizon-Beyond Check Point Inhibitors on 9/23. Welcomed to join us!

More Info: http://reg.csco.org.cn/